<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Caspian Journal of Pediatrics</title>
<title_fa>مجله کاسپین کودکان</title_fa>
<short_title>CJP</short_title>
<subject>Medical Sciences</subject>
<web_url>http://caspianjp.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2423-4729</journal_id_issn>
<journal_id_issn_online>2383-3106</journal_id_issn_online>
<journal_id_pii>0</journal_id_pii>
<journal_id_doi>10.22088/CJP.BUMS</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>0</journal_id_sid>
<journal_id_nlai>0</journal_id_nlai>
<journal_id_science>0</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1399</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2020</year>
	<month>9</month>
	<day>1</day>
</pubdate>
<volume>6</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Death of a steroid-dependent nephrotic syndrome patient taking levamisole: A case report</title>
	<subject_fa>عمومى</subject_fa>
	<subject>General</subject>
	<content_type_fa>گزارش مورد</content_type_fa>
	<content_type>case report</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;span style=&quot;font-size:14px;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;strong&gt;&lt;em&gt;&lt;span style=&quot;color:#006666;&quot;&gt;Background:&lt;/span&gt; &lt;/em&gt;&lt;/strong&gt;Levamisole is an anthelmintic drug used in the treatment of patients with a diagnosis of steroid-dependent nephrotic syndrome. Skin rash has been reported as a drug side effect, but adverse events are really rare.&lt;br&gt;
&lt;span style=&quot;color:#006666;&quot;&gt;&lt;strong&gt;&lt;em&gt;Case report:&lt;/em&gt;&lt;/strong&gt;&lt;/span&gt; The case presented in this article was a 14-year-old boy with steroid-dependent nephrotic syndrome, treated with levamisole due to frequent relapse. He was admitted with rash, weakness, fatigue, fever, and weight loss. Levamisole was discontinued, and the patient&amp;rsquo;s condition improved in the following two weeks. One year later, the nephrotic syndrome relapsed, and he received prednisolone and levamisole. He was admitted to the hospital six months after re-administration of these drugs because of vasculopathy, and unfortunately, he died due to disseminated intravascular coagulation (DIC).&lt;br&gt;
&lt;span style=&quot;color:#006666;&quot;&gt;&lt;strong&gt;&lt;em&gt;Conclusions:&lt;/em&gt;&lt;/strong&gt;&lt;/span&gt; Although levamisole is a suitable and cost-effective therapy for remission maintenance in steroid-dependent nephrotic syndrome, it is highly recommended to discontinue the drug without re-administration in case of reoccurring adverse effects, especially skin rash and systemic reaction, in addition to close monitoring of the patients under treatment.&lt;/span&gt;&lt;/span&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Child, Levamisole, Nephrotic Syndrome, Rash, Vasculopathy</keyword>
	<start_page>430</start_page>
	<end_page>433</end_page>
	<web_url>http://caspianjp.ir/browse.php?a_code=A-10-153-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>mahbobeh</first_name>
	<middle_name></middle_name>
	<last_name>neamatshahi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mahneamatshahi@yahoo.com</email>
	<code>10031947532846002778</code>
	<orcid>10031947532846002778</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of community Medicine, Faculty of Medicine, Research Center Social Determinants health, Sabzevar University of Medical Sciences, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Elham</first_name>
	<middle_name></middle_name>
	<last_name>Navipour</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Elham.navipour@gmail.com</email>
	<code>10031947532846002779</code>
	<orcid>10031947532846002779</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Anesthesiology, Faculty of Paramedicine, Sabzevar University of Medical Sciences, Sabzevar, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Zahra</first_name>
	<middle_name></middle_name>
	<last_name>Barabadi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>z.barabadi@umsha.ac.ir</email>
	<code>10031947532846002780</code>
	<orcid>10031947532846002780</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Tissue Engineering, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Aghil</first_name>
	<middle_name></middle_name>
	<last_name>Keykhosravi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>drakeykhosravi@yahoo.com</email>
	<code>10031947532846002781</code>
	<orcid>10031947532846002781</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of pediatrics, Faculty of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
